These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 31966825

  • 21. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 22. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.
    Lu L, Cai M, Peng M, Wang F, Zhai X.
    Cancer Manag Res; 2019 Mar 01; 11():1805-1816. PubMed ID: 30863186
    [Abstract] [Full Text] [Related]

  • 23. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.
    Eur J Cancer; 2014 Apr 01; 50(6):1207-21. PubMed ID: 24412052
    [Abstract] [Full Text] [Related]

  • 24. The Role of MicroRNA-1207-5p in Colorectal Cancer.
    Wang X, Wu X.
    Clin Lab; 2017 Nov 01; 63(11):1875-1882. PubMed ID: 29226644
    [Abstract] [Full Text] [Related]

  • 25. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP, Huang CC, Yeh KT, Ke TW, Wei PL, Yang JR, Cheng YW.
    Surg Oncol; 2016 Dec 01; 25(4):429-434. PubMed ID: 27262492
    [Abstract] [Full Text] [Related]

  • 26. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G, Wang R, Wang M.
    Cancer Biomark; 2019 Dec 01; 25(1):11-18. PubMed ID: 31006664
    [Abstract] [Full Text] [Related]

  • 27. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J.
    Oncotarget; 2015 Sep 15; 6(27):24448-62. PubMed ID: 26259252
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F, Jiang W, Yue B, Wang J, Zhang M, Yu Y, Liu X, Sun X, Zhou Z, Qin X, Zhang X, Yan D, Wen Y, Peng Z.
    Oncotarget; 2016 Jul 19; 7(29):45199-45213. PubMed ID: 27286257
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY.
    J Exp Clin Cancer Res; 2015 Aug 22; 34(1):86. PubMed ID: 26297223
    [Abstract] [Full Text] [Related]

  • 31. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E, Liu HN, Shen XZ, Liu TT.
    J Dig Dis; 2018 Jul 22; 19(7):404-410. PubMed ID: 29952077
    [Abstract] [Full Text] [Related]

  • 32. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.
    Qiu G, Zhang XB, Zhang SQ, Liu PL, Wu W, Zhang JY, Dai SR.
    Oncol Lett; 2016 Dec 22; 12(6):5036-5042. PubMed ID: 28101234
    [Abstract] [Full Text] [Related]

  • 33. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG, Tolkach Y, Deng M, Schmidt D, Perner S, Kristiansen G, Müller SC, Ellinger J.
    Clin Epigenetics; 2018 Dec 22; 10():11. PubMed ID: 29410711
    [Abstract] [Full Text] [Related]

  • 34. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A.
    Sci Rep; 2017 Mar 06; 7():43393. PubMed ID: 28262692
    [Abstract] [Full Text] [Related]

  • 35. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J, Dong P, Gao S, Wang N, Yu F.
    Hepatogastroenterology; 2013 May 06; 60(123):549-52. PubMed ID: 23108086
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY, Zheng YB, Liu J.
    Eur Rev Med Pharmacol Sci; 2018 Dec 06; 22(24):8657-8663. PubMed ID: 30575906
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y.
    Biomed Pharmacother; 2018 May 06; 101():945-952. PubMed ID: 29635904
    [Abstract] [Full Text] [Related]

  • 40. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H, Liu J, Chen Y, Ma C, Li B, Hao T.
    Cancer Med; 2016 Oct 06; 5(10):2932-2941. PubMed ID: 27592860
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.